A Randomized Placebo-Controlled Phase Ia Malaria Vaccine Trial of Two Virosome-Formulated Synthetic Peptides in Healthy Adult Volunteers
Blaise Genton, Gerd Pluschke, Lukas Degen et al. · 2007
Read A Randomized Placebo-Controlled Phase Ia Malaria Vaccine Trial of Two Virosome-Formulated Synthetic Peptides in Healthy Adult Volunteers by Blaise Genton, Gerd Pluschke, Lukas Degen et al. (2007) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0001018.txt.
Description
Blaise Genton, Gerd Pluschke, Lukas Degen and colleagues ran an early malaria vaccine trial using virus like carriers, in PLOS ONE in 2007. The trial used influenza virosomes, hollow virus shells that can carry other material safely. Virosomes had already proved fit for subunit vaccines, designs that use only pieces of a germ.
Two synthetic peptides, short malaria protein pieces, were mounted on the virosomes. Healthy adult volunteers received them in a randomized, placebo controlled phase one trial. The aim was proof of concept: can this carrier raise strong antibodies against malaria pieces. Early trials like this decide whether a vaccine idea earns larger tests.
Catalog record
| CREATOR | Blaise Genton, Gerd Pluschke, Lukas Degen et al. |
|---|---|
| YEAR | 2007 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 43 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0001018